ezetimibe and simvastatin tablet
1 INDICATIONS AND USAGE Ezetimibe and Simvastatin Tablets Ezetimibe and Simvastatin Tablets are combination of simvastatin and ezetimibe indicated: Simvastatin Simvastatin, when used as a component of ezetimibe and simvastatin tablets, is indicated to reduce the risk of total mortality by reducing risk of coronary heart disease death, non-fatal myocardial infarction and stroke, and the need for coronary and non-coronary revascularization procedures in adults with established coronary heart disease, cerebrovascular disease, peripheral vascular disease, and/or diabetes, who are at high risk of coronary heart disease events. • As an adjunct to diet to reduce elevated low density lipoprotein cholesterol (LDL-C): o In adults with primary hyperlipidemia. o In adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies to reduce elevated LDL-C in adults with homozygous familial hypercholesterolemia (HoFH). Simvastatin Simvastatin, when used as a component of ezetimibe and simvastatin tablets, is indicated to reduce the risk of total mortality by reducing risk of coronary heart disease death, non-fatal myocardial infarction and stroke, and the need for coronary and non-coronary revascularization procedures in adults with established coronary heart disease, cerebrovascular disease, peripheral vascular disease, and/or diabetes, who are at high risk of coronary heart disease events. Ezetimibe and simvastatin tablets are combination of simvastatin and ezetimibe indicated: ( 1 ) • As an adjunct to diet to reduce elevated low density lipoprotein cholesterol (LDL-C): o In adults with primary hyperlipidemia. o In adults and pediatric patients aged 10 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C lowering therapies to reduce LDL-C in adults with homozygous familial hypercholesterolemia (HoFH). Simvastatin Simvastatin, when used as a component of ezetimibe and simvastatin tablets, is indicated to reduce the risk of total mortality by reducing risk of coronary heart disease death, non-fatal myocardial infarction and stroke, and the need for coronary and non-coronary revascularization procedures in adults with established coronary heart disease, cerebrovascular disease, peripheral vascular disease, and/or diabetes, who are at high risk of coronary heart disease events.
glenmark pharmaceuticals inc., usa
OVAL WHITE G 321
Related Pills
ezetimibe and simvastatin tablet
glenmark pharmaceuticals inc., usa
ezetimibe and simvastatin tablet
glenmark pharmaceuticals inc., usa
ezetimibe and simvastatin tablet
glenmark pharmaceuticals inc., usa
lamotrigine tablet orally disintegrating
golden state medical supply, inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
EZETIMIBE AND SIMVASTATIN Tablets 10 mg/10 mg are white to off-white, capsule shaped, uncoated tablets debossed with ‘G’ on one side and ‘321’ on the other side. They are supplied as follows: Bottles of 30 NDC 68462-321-30 Bottles of 90 NDC 68462-321-90 Bottles of 1000 NDC 68462-321-10
EZETIMIBE AND SIMVASTATIN Tablets 10 mg/20 mg are white to off-white, capsule shaped, uncoated tablets debossed with ‘G’ on one side and ‘322’ on the other side. They are supplied as follows: Bottles of 30 NDC 68462-322-30 Bottles of 90 NDC 68462-322-90 Bottles of 1000 NDC 68462-322-10
EZETIMIBE AND SIMVASTATIN Tablets 10 mg/40 mg are white to off-white, capsule shaped, uncoated tablets debossed with ‘G’ on one side and ‘323’ on the other side. They are supplied as follows: Bottles of 30 NDC 68462-323-30 Bottles of 90 NDC 68462-323-90 Bottles of 500 NDC 68462-323-05
EZETIMIBE AND SIMVASTATIN Tablets 10 mg/80 mg are white to off-white, capsule shaped, uncoated tablets debossed with ‘G’ on one side and ‘324’ on the other side. They are supplied as follows: Bottles of 30 NDC 68462-324-30 Bottles of 90 NDC 68462-324-90 Bottles of 500 NDC 68462-324-05 Storage Store at 68°F to 77°F (20°C to 25°C) [see USP Controlled Room Temperature]. Keep container tightly closed.
More pills like OVAL G 321